CAMBRIDGE, Mass.--(BUSINESS WIRE)--Applications are now being accepted for Hacking Dermatology 2019, an innovation challenge that unites clinical and scientific experts, patients, engineers and innovators to reimagine the landscape of patient care. Winning teams will be awarded a total of $85,000 (USD) in grants and entered into an acceleration period to receive mentorship and access to resources to bring solutions to market. The hackathon takes place Sept 13-15, 2019, at District Hall in Bosto
MELBOURNE, Australia--(BUSINESS WIRE)--Propanc Biopharma, Inc. (OTC: PPCBD) (“Propanc”), a biopharmaceutical company developing new cancer treatments for patients suffering from recurring and metastatic cancer, announced today that Propanc’s intellectual property (“IP”) portfolio has undergone rapid growth recently, with sixty-five patents currently either in force or pending in most major countries and regions around the world. The IP covers Propanc’s underlying anti-cancer technology in devel
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου